TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring the business and assets of RTI, Inc.
TM Capital assisted Immucor, Inc. (NASDAQ) in forming a joint venture for distribution of Immucor’s products in Japan with Kainos Laboratories, Inc.
TM Capital advised Surpass Medical, Ltd. in its sale to Stryker Corporation (NYSE:SYK) for $135 million in cash and future consideration
TM Capital served as exclusive financial advisor to UltiMed, Inc., a portfolio company of LDI, Ltd., in its sale to an investment vehicle sub-managed by Levine Leichtman Capital Partners
TM Capital assisted Immucor, Inc. (NASDAQ) in the acquisition of the BCA division of Biopool International, Inc. (NASDAQ)